Walleye Trading LLC Anavex Life Sciences Corp. Call Options Transaction History

Walleye Trading LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$3.39 - $5.02 $24,747 - $36,646	-7,300 Reduced 24.17%	22,900 $96,000
Q1 2024 May 15, 2024	BUY	$4.55 - $6.75 $137,410 - $203,850	30,200 New	30,200 $153,000
Q2 2023 Aug 14, 2023	SELL	$7.66 - $9.5 $724,636 - $898,700	-94,600 Reduced 92.29%	7,900 $64,000
Q1 2023 May 15, 2023	BUY	$8.32 - $11.75 $852,800 - $1.2 Million	102,500 New	102,500 $878,000
Q2 2022 Aug 08, 2022	BUY	$7.31 - $12.84 $56,287 - $98,868	7,700 Added 641.67%	8,900 $89,000
Q1 2022 May 16, 2022	BUY	$9.74 - $17.69 $11,688 - $21,228	1,200 New	1,200 $15,000
Q4 2021 Feb 14, 2022	SELL	$16.88 - $23.31 $135,040 - $186,480	-8,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$16.82 - $25.75 $43,732 - $66,950	2,600 Added 48.15%	8,000 $144,000
Q2 2021 Aug 16, 2021	BUY	$10.16 - $28.86 $54,864 - $155,844	5,400 New	5,400 $123,000

154

27.3M

515K

838K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $581M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.